Quotient BioResearch Announces Extension of Rapidfact™ Into Non-Oral Routes of Delivery
3/19/2013 11:13:21 AM
More...
|
LGC Genomics GmbH Acquires Leading Bioanalytical Sciences Business From Quotient BioResearch
1/2/2013 10:23:51 AM
More...
|
Hat Trick for Quotient BioResearch at the East Cambridgeshire Business Awards
11/13/2012 1:55:40 PM
More...
|
Quotient BioResearch Discusses Biomarkers and Decision-Making in Drug Development
10/16/2012 11:26:03 AM
More...
|
Quotient BioResearch Investment in Bioanalytical Facility
10/2/2012 9:14:51 AM
More...
|
Quotient BioResearch Expands its Molecular Biology Services
8/2/2012 10:38:23 AM
More...
|
Quotient BioResearch Announces Completion and Publication of a RapidFACT™ Program for Eli Lilly and Company (LLY) to Develop an Optimised Drug Product for New Pain Medication
7/24/2012 9:59:55 AM
More...
|
Quotient BioResearch Announces Agreement with Phico Therapeutics and First Application of Rapidfact for Nasal Delivery
9/13/2011 11:57:46 AM
More...
|
Quotient BioResearch Announces the First Use of Ivmicrotracer to Support a Regulatory Drug Approval Submission
9/6/2011 11:30:44 AM
More...
|
Quotient BioResearch Expands Clinical Capacity in Response to Customer Adoption of Its Synthesis-to-Clinic Human ADME Service
5/5/2011 10:32:19 AM
More...
|
|